Synaptive Medical last week told the U.S. Securities & Exchange Commission that it raised $3.7 million in an equity round.
Toronto-based Synaptive, which makes brain imaging products, did not respond to requests for comment from Massdevice.com on the funding.
Eighteen unnamed investors participated in the round, which began last month, according to the filing. In addition to president & co-founder Cameron Piron, the filing lists Synaptive’s 3 other co-founders (Gal Sela, Wesley Hodges and David Gallop) as well as board members Doug Janzen, co-founder & managing director of NorthView Ventures, and ACAMS & Scribestar chairman Andrew Prozes.
In July, Synaptive said it won Health Canada approval for its BrightMatter Guide brain imaging system, which provides 3D visuals of the brain in the operating room to help guide surgeons.
The company has also won a series of regulatory nods in the U.S. this year, beginning with FDA clearance in April to start marketing its 3D brain visualization technology. In May, Synaptive said it won 510(k) clearance from the federal safety watchdog for its ImageDrive Pro informatics system.
In March, the neuro-imaging company expanded with its purchase of Clear Canvas for an undisclosed amount, giving it access to Clear Canvas’ imaging informatics technologies and a customer base of about 30,000 healthcare professionals globally.